{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:45Z","timestamp":1791229485868,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.mcna.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:22:00Z","timestamp":1622204520000},"page":"681-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cutaneous Manifestations of Diabetes"],"prefix":"10.1016","volume":"105","author":[{"given":"Alex","family":"Hines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2021.04.008_bib1","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib2","doi-asserted-by":"crossref","first-page":"14790","DOI":"10.1038\/s41598-020-71908-9","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul Health Metr"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40257-013-0048-2","article-title":"Relationship between skin diseases and extracutaneous complications of diabetes mellitus: clinical analysis of 750 patients","volume":"15","author":"Demirseren","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.20344\/amp.10738","article-title":"Cutaneous manifestations of diabetes mellitus and prediabetes","volume":"32","author":"Sanches","year":"2019","journal-title":"Acta Med Port"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib6","first-page":"A5316","article-title":"Specific skin signs as a cutaneous marker of diabetes mellitus and the prediabetic state: a systematic review","volume":"64","author":"Bustan","year":"2017","journal-title":"Danish Med J"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40257-017-0275-z","article-title":"Cutaneous manifestations of diabetes mellitus: a review","volume":"18","author":"Lima","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.008_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1468-3083.2012.04475.x","article-title":"Skin signs in diabetes mellitus","volume":"26","author":"Behm","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(94)70128-8","article-title":"Acanthosis nigricans","volume":"31","author":"Schwartz","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.mcna.2021.04.008_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D37MF6G290","article-title":"Acanthosis nigricans: a practical approach to evaluation and management","volume":"14","author":"Higgins","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.mcna.2021.04.008_bib11","first-page":"1","article-title":"The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans","author":"Treesirichod","year":"2020","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.008_bib12","first-page":"689","article-title":"Dermatologic disorders associated with diabetes mellitus","volume":"41","author":"Muller","year":"1966","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diacare.21.4.506","article-title":"The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications","volume":"21","author":"Yosipovitch","year":"1998","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archderm.1966.01600210008002","article-title":"Necrobiosis lipoidica diabeticorum","volume":"93","author":"Muller","year":"1966","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02663.x","article-title":"Necrobiosis lipoidica: only a minority of patients have diabetes mellitus","volume":"140","author":"O'Toole","year":"1999","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(08)80961-9","article-title":"Necrobiosis lipoidica","volume":"25","author":"Lowitt","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib17","first-page":"68","article-title":"Dermatologic manifestation of diabetes","volume":"4","author":"Levy","year":"2012","journal-title":"J\u00a0Diabetes"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ecl.2013.07.004","article-title":"Dermatologic manifestations of diabetes mellitus: a review","volume":"42","author":"Murphy-Chutorian","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.det.2015.03.003","article-title":"Necrobiosis lipoidica","volume":"33","author":"Sibbald","year":"2015","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib20","first-page":"E21","article-title":"A\u00a0new appraisal of dermatologic manifestations of diabetes mellitus","volume":"94","author":"Han","year":"2014","journal-title":"Cutis"},{"issue":"12","key":"10.1016\/j.mcna.2021.04.008_bib21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/ijd.13610","article-title":"A\u00a0systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus","volume":"56","author":"Mistry","year":"2017","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaad.2007.11.013","article-title":"Diabetic dermopathy: a subtle sign with grave implications","volume":"58","author":"Morgan","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2337\/diaclin.33.1.40","article-title":"Cutaneous manifestations of diabetes mellitus","volume":"33","author":"Duff","year":"2015","journal-title":"Clin Diabetes"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-4362.1998.00273.x","article-title":"Diabetic dermopathy and internal complications in diabetes mellitus","volume":"37","author":"Shemer","year":"1998","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0190-9622(87)70072-3","article-title":"Pathologic features of diabetic thick skin","volume":"16","author":"Hanna","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.43.2.251","article-title":"Limitation of joint mobility (cheiroarthropathy) in adult noninsulin-dependent diabetic patients","volume":"43","author":"Fitzcharles","year":"1984","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00570538","article-title":"Association between \"diabetic thick skin syndrome\" and neurological disorders in diabetes mellitus","volume":"31","author":"Forst","year":"1994","journal-title":"Acta Diabetol"},{"issue":"16","key":"10.1016\/j.mcna.2021.04.008_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM198010163031615","article-title":"Reduced skin thickness with pump administration of insulin","volume":"303","author":"Lieberman","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diacare.6.2.189","article-title":"Scleredema diabeticorum: a common and distinct cutaneous manifestation of diabetes mellitus","volume":"6","author":"Cole","year":"1983","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1464-5491.1988.tb01030.x","article-title":"Scleroedema diabeticorum: a minor but often unrecognized complication of diabetes mellitus","volume":"5","author":"Sattar","year":"1988","journal-title":"Diabet Med"},{"issue":"12","key":"10.1016\/j.mcna.2021.04.008_bib31","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/jdv.13272","article-title":"Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients","volume":"29","author":"Rongioletti","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib32","first-page":"281","article-title":"[Obesity persistent scleredema: study of 49 cases]","volume":"129","author":"Ray","year":"2002","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/00015555-2846","article-title":"Treatment of scleroedema adultorum Buschke: a systematic review","volume":"98","author":"Miguel","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdiacomp.2008.12.009","article-title":"The diabetic hand: a forgotten complication?","volume":"24","author":"Papanas","year":"2010","journal-title":"J\u00a0Diabetes Complications"},{"issue":"6525","key":"10.1016\/j.mcna.2021.04.008_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bmj.292.6525.936","article-title":"Change in skin thickness associated with cheiroarthropathy in insulin dependent diabetes mellitus","volume":"292","author":"Collier","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0019-5154.60349","article-title":"Pattern of cutaneous manifestations in diabetes mellitus","volume":"55","author":"Goyal","year":"2010","journal-title":"Indian J Dermatol"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8227(97)00119-8","article-title":"Skin lesions in diabetes mellitus: prevalence and clinical correlations","volume":"39","author":"Romano","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib38","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/bjd.13077","article-title":"Spectrum of cutaneous manifestations of type 1 diabetes mellitus in 500 South Asian patients","volume":"171","author":"Sawatkar","year":"2014","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1742-481X.2008.00476.x","article-title":"Incidence of bullosis diabeticorum: a controversial cause of chronic foot ulceration","volume":"5","author":"Larsen","year":"2008","journal-title":"Int Wound J"},{"issue":"3","key":"10.1016\/j.mcna.2021.04.008_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-4362.2000.00947.x","article-title":"Diabetic bullae: 12 cases of a purportedly rare cutaneous disorder","volume":"39","author":"Lipsky","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mcna.2021.04.008_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.12659\/AJCR.905452","article-title":"Bullosis Diabeticorum: A rare presentation with immunoglobulin G (IgG) deposition related vasculopathy. Case report and focused review","volume":"19","author":"Sonani","year":"2018","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib42","doi-asserted-by":"crossref","first-page":"1.e1-18","DOI":"10.1016\/j.jaad.2013.07.048","article-title":"Diabetic foot ulcers: Part I. Pathophysiology and prevention","volume":"70","author":"Alavi","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib43","doi-asserted-by":"crossref","first-page":"21.e21-4","DOI":"10.1016\/j.jaad.2013.07.048","article-title":"Diabetic foot ulcers: Part II. Management","volume":"70","author":"Alavi","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mcna.2021.04.008_bib44","series-title":"Endotext","first-page":"2000","article-title":"Skin manifestations of diabetes mellitus","author":"Rosen","year":"2018"},{"issue":"10","key":"10.1016\/j.mcna.2021.04.008_bib45","first-page":"636","article-title":"Diabetes mellitus and the skin: recognition and management of cutaneous manifestations","volume":"109","author":"Horton","year":"2016","journal-title":"South Med J"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1468-3083.2010.03807.x","article-title":"Importance of treatment of skin xerosis in diabetes","volume":"25","author":"Seite","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/ced.14363","article-title":"Comparison of transepidermal water loss and skin hydration in diabetics and nondiabetics","volume":"46","author":"Lai","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.mcna.2021.04.008_bib48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(18)30217-5","article-title":"Clinical presentation, management, and pathophysiology of neuropathic itch","volume":"17","author":"Steinhoff","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey","volume":"139","author":"Gupta","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-4632.2008.03606.x","article-title":"Metabolic syndrome associated with toenail onychomycosis in Taiwanese with diabetes mellitus","volume":"47","author":"Chang","year":"2008","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib51","first-page":"603","article-title":"Skin and nail mycoses in patients with diabetic foot","volume":"148","author":"Papini","year":"2013","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"3\u20134","key":"10.1016\/j.mcna.2021.04.008_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1439-0507.2001.00624.x","article-title":"Prevalence of dermatophytic skin and nail infections in diabetic patients","volume":"44","author":"Romano","year":"2001","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib53","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1365-2133.1996.tb06322.x","article-title":"The prevalence of dermatophyte infection in well-controlled diabetics and the response to Trichophyton antigen","volume":"134","author":"Buxton","year":"1996","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib54","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/dc05-2031","article-title":"Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study","volume":"29","author":"Boyko","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib55","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.12968\/bjon.2017.26.6.S6","article-title":"Foot ulceration in patients with diabetes: a risk analysis","volume":"26","author":"Rossaneis","year":"2017","journal-title":"Br J Nurs"},{"key":"10.1016\/j.mcna.2021.04.008_bib56","first-page":"CD010031","article-title":"Oral antifungal medication for toenail onychomycosis","volume":"7","author":"Kreijkamp-Kaspers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Suppl","key":"10.1016\/j.mcna.2021.04.008_bib57","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1067\/mjd.2000.110376","article-title":"Onychomycosis and tinea pedis in patients with diabetes","volume":"43","author":"Rich","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"131","key":"10.1016\/j.mcna.2021.04.008_bib58","first-page":"43","article-title":"[Characteristic changes of skin and its accessories in type 2 diabetes mellitus]","author":"Nikoleishvili","year":"2006","journal-title":"Georgian Med News"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7547\/1010049","article-title":"Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors","volume":"101","author":"Gulcan","year":"2011","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2021.04.008_bib60","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.cmi.2015.03.024","article-title":"Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections","volume":"21","author":"Dryden","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.mcna.2021.04.008_bib61","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2337\/diacare.24.6.1044","article-title":"Diabetes and the risk of infection-related mortality in the U.S","volume":"24","author":"Bertoni","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.mcna.2021.04.008_bib62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib63","doi-asserted-by":"crossref","first-page":"e60057","DOI":"10.1371\/journal.pone.0060057","article-title":"Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S","volume":"8","author":"Suaya","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.mcna.2021.04.008_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40257-018-0400-7","article-title":"Cutaneous adverse effects of diabetes mellitus medications and medical devices: a review","volume":"20","author":"Jedlowski","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2021.04.008_bib65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/cod.13075","article-title":"Allergic contact dermatitis caused by isobornyl acrylate in a young diabetic patient using a continuous glucose monitoring system (Freestyle Libre)","volume":"79","author":"Corazza","year":"2018","journal-title":"Contact Dermatitis"},{"issue":"12","key":"10.1016\/j.mcna.2021.04.008_bib66","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1111\/jdv.14957","article-title":"Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors","volume":"32","author":"Gravani","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.mcna.2021.04.008_bib67","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/jdv.14649","article-title":"Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade","volume":"32","author":"Fania","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.mcna.2021.04.008_bib68","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-0409","article-title":"Dipeptidyl peptidase 4 inhibitors and the risk of bullous pemphigoid among patients with type 2 diabetes","volume":"42","author":"Douros","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T19:11:32Z","timestamp":1725131492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0025712521000468"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Manifestations of Diabetes","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}